Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3826
Strive Emerging Markets ex-China ETF
STXE
$144M
| $668K | ﹤0.01% |
21,524
+12,862
| +148% | +$371K |
2024 Q4
2 quarters
|
|
3827
Achieve Life Sciences
ACHV
$775M
| $667K | ﹤0.01% |
295,058
+107,218
| +57% | +$305K |
2024 Q4
2 quarters
|
|
3828
Teekay Tankers
TNK
$3.5B
| $667K | ﹤0.01% |
15,978
+366
| +2% | +$15.7K |
2024 Q4
2 quarters
|
|
3829
Rhythm Pharmaceuticals
RYTM
$6.43B
| $666K | ﹤0.01% |
+10,546
| New | +$646K |
2025 Q2
0 quarters
|
|
|
HNW
3830
DELISTED
Pioneer Diversified High Income Fund
HNW
| $661K | ﹤0.01% |
52,892
-708
| -1% | -$8.48K |
2024 Q4
2 quarters
|
|
3831
Clearfield
CLFD
$437M
| $659K | ﹤0.01% |
15,191
-4,300
| -22% | -$147K |
2024 Q4
2 quarters
|
|
3832
Noble Corp
NE
$6.66B
| $659K | ﹤0.01% |
24,829
+8,649
| +53% | +$208K |
2024 Q4
2 quarters
|
|
3833
Relay Therapeutics
RLAY
$4.05B
| $659K | ﹤0.01% |
190,488
+5,955
| +3% | +$17.7K |
2024 Q4
2 quarters
|
|
|
SABA
3834
Saba Capital Income & Opportunities Fund II
SABA
$213M
| $656K | ﹤0.01% |
71,402
+1,997
| +3% | +$17.3K |
2024 Q4
2 quarters
|
|
|
EAOK
3835
DELISTED
iShares ESG Aware Conservative Allocation ETF
EAOK
| $655K | ﹤0.01% |
24,603
+3,283
| +15% | +$84.7K |
2024 Q4
2 quarters
|
|
|
FTHY
3836
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$463M
| $654K | ﹤0.01% |
44,044
+1,225
| +3% | +$17.4K |
2024 Q4
2 quarters
|
|
|
SPNS
3837
DELISTED
Sapiens International
SPNS
| $653K | ﹤0.01% |
+22,341
| New | +$623K |
2025 Q2
0 quarters
|
|
3838
Barnes & Noble Education
BNED
$405M
| $653K | ﹤0.01% |
55,445
-990
| -2% | -$10.6K |
2025 Q1
1 quarter
|
|
3839
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$454M
| $651K | ﹤0.01% |
16,321
+1,184
| +8% | +$45.5K |
2024 Q4
2 quarters
|
|
|
LPRO
3840
DELISTED
Open Lending Corp
LPRO
| $651K | ﹤0.01% |
335,356
-281,767
| -46% | -$455K |
2024 Q4
2 quarters
|
|
|
ONL
3841
Orion Office REIT
ONL
$139M
| $650K | ﹤0.01% |
305,109
+5,242
| +2% | +$9.99K |
2024 Q4
2 quarters
|
|
3842
Moog Inc Class B
MOG.B
$12.4B
| $649K | ﹤0.01% |
3,587
-44
| -1% | -$7.44K |
2024 Q4
2 quarters
|
|
3843
Bankunited
BKU
$3.04B
| $648K | ﹤0.01% |
+18,206
| New | +$611K |
2025 Q2
0 quarters
|
|
3844
Invesco S&P SmallCap Industrials ETF
PSCI
$271M
| $648K | ﹤0.01% |
4,832
-66,360
| -93% | -$8.13M |
2024 Q4
2 quarters
|
|
3845
SoFi Select 500 ETF
SFY
$701M
| $645K | ﹤0.01% |
5,464
+121
| +2% | +$12.9K |
2024 Q4
2 quarters
|
|
3846
CytomX Therapeutics
CTMX
$573M
| $644K | ﹤0.01% |
+283,560
| New | +$457K |
2025 Q2
0 quarters
|
|
3847
Genmab
GMAB
$21.6B
| $643K | ﹤0.01% |
31,146
+10,113
| +48% | +$208K |
2024 Q4
2 quarters
|
|
3848
Dorchester Minerals
DMLP
$1.4B
| $643K | ﹤0.01% |
23,092
-1,378
| -6% | -$38.7K |
2024 Q4
2 quarters
|
|
|
BELFB
3849
Bel Fuse Inc Class B
BELFB
$3.64B
| $642K | ﹤0.01% |
+6,576
| New | +$496K |
2025 Q2
0 quarters
|
|
3850
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$26.7M
| $641K | ﹤0.01% |
8,708
+1,023
| +13% | +$69.5K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.